U.S. Clinical Trials Supply And Logistics Market Size, Share & Trends Analysis Report By Service (Logistics & Distribution, Storage & Retention, Packaging, Labeling & Blinding), By Phase, By Therapeutic Area, By End-use, And Segment Forecasts, 2025 - 2033

U.S. Clinical Trials Supply & Logistics Market Summary

The U.S. clinical trials supply and logistics market size was estimated at USD 1.40 billion in 2024 and is projected to reach USD 2.87 billion by 2033, growing at a CAGR of 8.45% from 2025 to 2033. The market has experienced robust growth driven by research and development activities for innovative therapeutic areas such as oncology, rare diseases, and cell and gene therapies.

Besides, the growing complexity of trial designs and regulatory requirements for patient safety and product integrity has led to the need for advanced supply chain models. Further, the adoption of decentralized trials and direct-to-patient delivery solutions has highlighted the significance of flexible and compliant logistics networks. In addition, increased investment from pharmaceutical and biotech companies has enhanced the demand for efficient packaging, temperature-controlled storage, and distribution services essential for timely trial execution.

Moreover, most clinical trials across various phases have been supported by specialized supply solutions such as cold chain distribution, comparator sourcing, clinical packaging, and return management. Smaller batch distributions with tight timelines have been effectively managed for early-phase studies through adaptable supply models, while large-scale Phase III trials benefit from comprehensive global depot networks. Besides, the expanding pipeline of biologics, biosimilars, and advanced therapies has further boosted the need for ultra-low temperature handling and specialized transportation solutions. As trials broaden in scope and geographical reach, supply and logistics providers have become crucial in ensuring the continuous availability of investigational products. Their role has been vital in fueling market expansion by minimizing delays, ensuring compliance, and enhancing trial efficiency.

Furthermore, established market players are pursuing strategic initiatives, including acquisitions, service expansions, and investments in digital platforms to enhance visibility and tracking. Collaborations with sponsors and contract research organizations (CROs) are being accelerated, focusing on increasing cold chain capacity in the U.S. to address the challenges posed by growing trial complexity. Such factors are expected to drive the market over the estimated timeframe.

U.S. Clinical Trials Supply And Logistics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. clinical trials supply & logistics market report based on service, phase, therapeutic area, and end-use.

• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Other Services
• Phase Outlook (Revenue, USD Million, 2021 - 2033)
• Phase I
• Phase II
• Phase III
• Phase IV
• Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS And Mental Disorders
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceuticals
• Biologicals
• Medical Device

Please note The report will be delivered in 2-3 business days upon order notification. Show more